The Bioprocessing Summit-Virtual

Join our Biotech Community at The Bioprocessing Summit–being held as a virtual event this year. The program will feature industry and technical thought leaders sharing their insight and expertise on upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing.

Be sure to tune in to our presentation on Friday, August 28, 2020 at 10:45am EDT, titled “Modeling MVM Clearance with a Non-Infectious Viral Surrogate.” This presentation by Dr. Akunna Iheanacho, Director of Research & Development, Texcell will address the viral clearance capabilities of an affinity resin engineered for adeno-associated virus (AAV) gene therapy applications and utilized a non-infectious viral surrogate to define the operational space in which MVM is removed.

For more information, please visit: https://www.bioprocessingsummit.com/